Literature DB >> 1542549

Osteocalcin, skeletal alkaline phosphatase, and bone mineral content in very low birth weight infants: a longitudinal assessment.

W B Pittard1, K M Geddes, T C Hulsey, B W Hollis.   

Abstract

Serum osteocalcin (Gla) and skeletal alkaline phosphatase (SAP) concentration both reflect osteoblast activity in the dynamic process of bone formation. To assess the relation in premature infants between change in bone mineral content (BMC) and both Gla and SAP serum concentration, we longitudinally measured BMC via photon absorptiometry and serum Gla and SAP concentration from birth to 16 wk in 20 very low birth weight infants. Serum total calcium, phosphorus, parathyroid hormone, and vitamin D metabolite concentrations were also monitored. All serum values were measured in the 20 mothers at delivery. Cord blood Gla concentrations were significantly (p less than 0.03) greater than maternal levels, and by 1 wk had significantly (p less than 0.001) increased from birth values. Total calcium, parathyroid hormone, phosphorus, and vitamin D concentrations remained in the normal range throughout the study. The increase in serum Gla concentrations, birth to 1 wk, were significantly correlated with the simultaneous increase in 1,25-dihydroxyvitamin D concentrations. The correlation between the change in BMC, however, over the first 4 mo of life and both Gla and SAP serum concentrations failed to reach statistical significance. Finally, a significant (p less than 0.003) negative correlation was measured between serum Gla and SAP concentrations at wk 4, and, although not significant, a consistently negative correlation was measured from 1-16 wk of age.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542549     DOI: 10.1203/00006450-199202000-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants.

Authors:  M C Backström; R Mäki; A L Kuusela; H Sievänen; A M Koivisto; R S Ikonen; T Kouri; M Mäki
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

2.  Clinical-laboratory findings of bone metabolism in healthy premature and full-term neonates: preliminary results.

Authors:  Charalampos Dokos; Christos Tsakalidis; Kyriakoula Manaridou; Paraskevi Karayianni; Ioannis Kyrkos; Israel Roussos
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

3.  Metabolic bone disease in the preterm infant: Current state and future directions.

Authors:  Moghis Ur Rehman; Hassib Narchi
Journal:  World J Methodol       Date:  2015-09-26

Review 4.  Inside the "fragile" infant: pathophysiology, molecular background, risk factors and investigation of neonatal osteopenia.

Authors:  Charalampos Dokos; Christos Tsakalidis; Athanasios Tragiannidis; Dimitrios Rallis
Journal:  Clin Cases Miner Bone Metab       Date:  2013-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.